Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Consolidated Net Income (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Consolidated Net Income data on record, last reported at $237000.0 in Q4 2025.

  • For Q4 2025, Consolidated Net Income fell 67.45% year-over-year to $237000.0; the TTM value through Oct 2025 reached $2.4 million, up 506.52%, while the annual FY2025 figure was $4.7 million, 164.61% up from the prior year.
  • Consolidated Net Income reached $237000.0 in Q4 2025 per CSBR's latest filing, up from -$466000.0 in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $4.5 million in Q1 2025 and bottomed at -$2.6 million in Q3 2023.
  • Average Consolidated Net Income over 5 years is -$354300.0, with a median of -$245500.0 recorded in 2021.
  • Peak YoY movement for Consolidated Net Income: skyrocketed 27600.0% in 2021, then crashed 12843.75% in 2023.
  • A 5-year view of Consolidated Net Income shows it stood at $277000.0 in 2021, then crashed by 105.78% to -$16000.0 in 2022, then plummeted by 12843.75% to -$2.1 million in 2023, then soared by 135.15% to $728000.0 in 2024, then crashed by 67.45% to $237000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Consolidated Net Income were $237000.0 in Q4 2025, -$466000.0 in Q3 2025, and -$1.8 million in Q2 2025.